A LITERATURE REVIEW OF HYPERTENSION FACTORS IN PREGNANT WOMEN
Keywords:
hypertension, pregnant womenAbstract
Introduction: Hypertension in pregnancy is one of the most common complications that can lead to death after blood loss and infection. Hypertension affects approximately 10% of pregnancies and contributes significantly to maternal and perinatal deaths. This study aimed to analyze the risk factors associated with hypertension in pregnant women. Methods: The research literature review method was used to search for articles on scientific sites such as ScienceDirect, PubMed, and Google Scholar using the keywords hypertension and pregnancy. Results: Of the 168 articles obtained, only eight met the criteria and described the risk factors associated with hypertension in pregnant women. Conclusions: The risk factors associated with hypertension in pregnant women include a history of hypertension, cigarette smoking, obesity, exercise, salt consumption, stress, age, and parity. The results are expected to provide additional information on the factors causing hypertension in pregnant women.References
Babys D, Idris I, Prihantono. Differences in serum magnesium levels, folic acid, and infant outcomes in severe preeclampsia: A literature review. Med Clin Pract. 2021;4:100221.
Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2):S1071-S1097.e2.
Chen Y, Ou QX, Chen Y, Zhu QL, Tan MH, Zhang MM, et al. Association between trace elements and preeclampsia: A retrospective cohort study. J Trace Elem Med Biol. 2022;72:126971.
Maher GM, Khashan AS, O’Byrne L, Flanagan S, Mortimer RM, Kiely M, et al. Periconceptual and prenatal alcohol consumption and neurodevelopment at age two and five years. Eur J Obstet Gynecol Reprod Biol. 2022;274(April):197–203.
Marasing IN, Idris I, Sunarno I, Arifuddin S, Sinrang AW, Bahar B. Comparison of nitric oxide levels, roll over test value, and body mass index in preeclampsia and normotension. Gac Sanit. 2021;35:S306–9.
Miller EC, Wilczek A, Bello NA, Tom S, Wapner R, Suh Y. Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics. Ageing Res Rev. 2022;73(January):20–2.
Sasmaya PH, Khalid AF, Anggraeni D, Irianti S, Akbar MR. Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia. Eur J Obstet Gynecol Reprod Biol X. 2022;13:1–5.
Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. Am J Obstet Gynecol. 1997;177(5):1003–10.
Wu SZ, Xu HY, Chen Y, Chen Y, Zhu QL, Tan MH, et al. Association of blood lead levels with preeclampsia: A cohort study in China. Environ Res. 2021;195:110822.
Bakouei F, Delavar MA, Mashayekh-Amiri S, Esmailzadeh S, Taheri Z. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis. Taiwan J Obstet Gynecol. 2020;59(1):8–15.
Bhutani N, Jethani V, Jethani S, Ratwani K. Coagulation profile and platelet parameters in pregnancy induced hypertension cases and normotensive pregnancies?: A cross-sectional study. Ann Med Surg. 2022;80(April):104124.
Cameron NA, Molsberry R, Pierce JB, Perak AM, Grobman WA, Allen NB, et al. Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States. J Am Coll Cardiol. 2020;76(22):2611–9.
Committee P. Society for Maternal-Fetal Medicine Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy–The Chronic Hypertension and Pregnancy trial. Am J Obstet Gynecol. 2022;(August):24–7.
de Haas S, Mulder E, Schartmann N, Mohseni Z, Abo Hasson F, Alsadah F, et al. Blood pressure adjustments throughout healthy and hypertensive pregnancy: A systematic review and meta-analysis. Pregnancy Hypertens. 2022;27(April 2021):51–8.
Fakhouri F, Scully M, Provot F, Blasco M, Coppo P, Noris M, et al. Management of thrombotic microangiopathy in pregnancy and postpartum: Report from an international working group. Blood. 2020;136(19):2103–17.
Ferrari B, Peyvandi F. How I treat thrombotic thrombocytopenic purpura in pregnancy. Blood. 2020;136(19):2125–32.
Fletcher B, Chappell LC, Lavallee L, Wilson HM, Stevens R, Mackillop L, et al. Changes to management of hypertension in pregnancy, and attitudes to self-management: An online survey of obstetricians, before and following the first wave of the COVID-19 pandemic. Pregnancy Hypertens. 2021;26(July):54–61.
García-Romero CS, Guzman C, Cervantes A, Cerbón M. Liver disease in pregnancy: Medical aspects and their implications for mother and child. Ann Hepatol. 2019;18(4):553–62.
Goddard J, Wee MYK, Vinayakarao L. Update on hypertensive disorders in pregnancy. BJA Educ. 2020;20(12):411–6.
Gonzalez Suarez ML, Kattah A, Grande JP, Garovic V. Renal Disorders in Pregnancy: Core Curriculum 2019. Am J Kidney Dis. 2019;73(1):119–30.
Guimarães T, Magalhães A, Veiga A, Fiuza M, Ávila W, Pinto FJ. Heart disease and pregnancy: State of the art. Rev Port Cardiol (English Ed. 2019;38(5):373–83.
Issue S, Community T, Lampung E, Wulandari LA, Retno SN. Jurnal Aisyah?: Jurnal Ilmu Kesehatan Autogenic Relaxation on Anxiety Among Pregnant Women at. 2022;7:1–8.
Katsafanas C, Bushnell C. Pregnancy and stroke risk in women. Neurobiol Dis. 2022;169(September 2021):105735.
Lane-Cordova AD, Khan SS, Grobman WA, Greenland P, Shah SJ. Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;73(16):2106–16.
López-Muñoz E, Mateos-Sánchez L, Mejía-Terrazas GE, Bedwell-Cordero SE. Hypothyroidism and isolated hypothyroxinemia in pregnancy, from physiology to the clinic. Taiwan J Obstet Gynecol. 2019;58(6):757–63.
Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022;27(September 2021):148–69.
Magee LA, Khalil A, Kametas N, von Dadelszen P. Toward personalized management of chronic hypertension in pregnancy. Am J Obstet Gynecol. 2022;226(2):S1196–210.
Marson EJ, Kamarajah SK, Dyson JK, White SA. Pregnancy outcomes in women with liver transplants: systematic review and meta-analysis. Hpb. 2020;22(8):1102–11.
McNeil A, Chen J, Meng ML. Pulmonary hypertension in pregnancy-the Anesthesiologist’s perspective. Int J Cardiol Congenit Hear Dis. 2021;5(June):100234.
Partash N, Naghipour B, Rahmani SH, Pashaei Asl Y, Arjmand A, Ashegvatan A, et al. The impact of flood on pregnancy outcomes: A review article. Taiwan J Obstet Gynecol. 2022;61(1):10–4.
Prendes CF, Christersson C, Mani K. Pregnancy and Aortic Dissection. Eur J Vasc Endovasc Surg. 2020;60(2):309–11.
Smith ER, Oakley E, Grandner GW, Rukundo G, Ferguson K, Baumann S, et al. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis. Am J Obstet Gynecol. 2022;(June).
Tan JS, Liu NN, Guo TT, Hu S, Hua L. Genetic predisposition to COVID-19 may increase the risk of hypertension disorders in pregnancy: A two-sample Mendelian randomization study. Pregnancy Hypertens. 2021;26(July):17–23.
Teirilä L, Heikkinen-Eloranta J, Kotimaa J, Meri S, Lokki AI. Regulation of the complement system and immunological tolerance in pregnancy. Semin Immunol. 2019;45(June):101337.
Tsen LC, Gelman S. The venous system during pregnancy. Part 2: clinical implications. Int J Obstet Anesth. 2022;50(February):103274.
Vanky E, Løvvik TS. Polycystic ovary syndrome and pregnancy – From a clinical perspective. Curr Opin Endocr Metab Res. 2020;12:8–13.
Aryal SR, Moussa H, Sinkey R, Dhungana R, Tallaj JA, Pamboukian S V., et al. Management of reproductive health in patients with pulmonary hypertension. Am J Obstet Gynecol MFM. 2020;2(2):100087.
Bijl RC, Cornette JMJ, Brewer AN, Zwart IF, Franx A, Tsigas EZ, et al. Patient-reported preconceptional characteristics in the prediction of recurrent preeclampsia. Pregnancy Hypertens. 2022;28(January):44–50.
Alves VP, de Oliveira RC, Gregori D. Non-communicable chronic diseases: Mortality of older adult citizens in Brazil and Italy before the Covid-19 pandemic. Heal Policy OPEN. 2021;2(June):100041.
Cagnacci A, Londero A Pietro, Xholli A. Case Reports in Women ’ s Health. Case Reports Women’s Heal. 2022;34:e00389.
Chikowore T, Kamiza AB, Oduaran OH, Machipisa T, Fatumo S. Non-communicable diseases pandemic and precision medicine: Is Africa ready? EBioMedicine. 2021;65:103260.
Dhawan D, Sharma S. Abdominal Obesity, Adipokines and Non-communicable Diseases. J Steroid Biochem Mol Biol. 2020;203(July):105737.
Anisa & Sofwan. Indonesian Journal of Public Health and Nutrition Article Info. Indones J Public Heal Nutr. 2021;1(1):101–13.
Ahmed A, Liang M, Chi L, Zhou YQ, Sled JG, Wilson MD, et al. Maternal obesity persistently alters cardiac progenitor gene expression and programs adult-onset heart disease susceptibility. Mol Metab. 2021;43(November 2020):101116.
Albåge A, Alström U, Forsblad J, Welin S. Quadruple Bioprosthetic Valve Replacement in a Patient With Severe Carcinoid Heart Disease. JACC Case Reports. 2020;2(2):271–6.
Arabloo J, Omidi N, Rezapour A, Sarabi Asiabar A, Mojtaba Ghorashi S, Azari S. The burden of nonrheumatic valvular heart diseases in Iran between 1990 and 2017: Results from the global burden of disease study 2017. IJC Hear Vasc. 2022;39(January):100956.
Bektas ?, K?r M, Y?ld?z K, Genç Z, Bektas M, Ünal N. Symptom Frequency in Children with Congenital Heart Disease and Parental Care Burden in Predicting the Quality of Life of Parents in Turkey. J Pediatr Nurs. 2020;53(xxxx):e211–6.
Bell J, Alhudairy M, Kazakova V, Johnstone M, Tsao L. Right and Left-Sided Carcinoid Heart Disease in the Setting of Selective Serotonin Reuptake Inhibitor Use. JACC Case Reports. 2020;2(12):1841–4.
Bichard E, McKeever S, Bench S, Wray J. Experiences of siblings of children with congenital heart disease during Coronavirus disease 2019; A qualitative interview study. J Pediatr Nurs. 2022;(xxxx).
Chami J, Nicholson C, Strange G, Baker D, Cordina R, Celermajer DS. Hospital discharge codes and substantial underreporting of congenital heart disease. Int J Cardiol Congenit Hear Dis. 2022;7(November 2021):100320.
Ciriello GD, Colonna D, Romeo E, Sarubbi B. Cardiac resynchronization therapy-defibrillator implantation guided by electroanatomic mapping in a young adult patient with congenital heart disease. Indian Pacing Electrophysiol J. 2022;(xxxx):3–6.
Cui J, Song L. Wrist pulse diagnosis of stable coronary heart disease based on acoustics waveforms. Comput Methods Programs Biomed. 2022;214:106550.
Diffenderfer MR, Rajapakse N, Pham E, He L, Dansinger ML, Nelson JR, et al. Plasma fatty acid profiles: relationships with sex, age, and state-reported heart disease mortality rates in the United States. J Clin Lipidol. 2022;1–13.
Flügge AK, Wasmer K, Orwat S, Abdul-Khaliq H, Helm PC, Bauer U, et al. Cardiac resynchronization therapy in congenital heart disease: Results from the German National Register for Congenital Heart Defects. Int J Cardiol. 2018;273:108–11.
Gooding HC, Brown CA, Revette AC, Vaccarino V, Liu J, Patterson S, et al. Young Women’s Perceptions of Heart Disease Risk. J Adolesc Heal. 2020;67(5):708–13.
Harrison DJ, Uzark K, Yu S, Lowery R, Yetman AT, Cramer J, et al. Transition readiness in congenital heart disease: Are teens and young adults getting the recommended information? Int J Cardiol Congenit Hear Dis. 2021;7(November 2021):100311.
Heyden CM, Moore JW, Ryan JR, Lederman RJ, El-Said HG, Ratnayaka K. Alternative Access in Congenital Heart Disease. JACC Case Reports. 2020;2(11):1734–5.
Hossain MA, Kim J-H. Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review. J Ginseng Res. 2022;(xxxx).
